Identification of optimal reference genes for gene expression studies in a focal cerebral ischaemia model-Spatiotemporal effects.


Journal

Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777

Informations de publication

Date de publication:
05 2022
Historique:
revised: 17 02 2022
received: 30 03 2021
accepted: 21 02 2022
pubmed: 23 4 2022
medline: 18 5 2022
entrez: 22 4 2022
Statut: ppublish

Résumé

A proper reference gene (RG) is required to reliably measure mRNA levels in biological samples via quantitative reverse transcription PCR (RT-qPCR). Various experimental paradigms require specific and stable RGs. In studies using rodent models of brain ischaemia, a variety of genes, such as β-actin (Actb), hypoxanthine phosphoribosyltransferase 1 (Hprt1), peptidyl-propyl isomerase A (Ppia) and glyceraldehyde-3-phosphate dehydrogenase (Gapdh), are used as RGs. However, most of these genes have not been validated in specific experimental settings. The aim of this study was to evaluate the time- and brain region-dependent expression of RG candidates in a rat model of transient middle cerebral artery occlusion (tMCAO). The following genes were selected: Actb, Hprt1, Ppia, Gapdh, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta (Ywhaz) and beta-2 microglobulin (B2m). Focal cerebral ischaemia was induced by 90 min of tMCAO in male Sprague-Dawley rats. Expression was investigated at four time points (12 and 24 h; 3 and 7 days) and in three brain areas (the frontal cortex, hippocampus and dorsal striatum) within the ischaemic brain hemisphere. The RT-qPCR results were analysed using variance analysis and the ΔCt, GeNorm, NormFinder and BestKeeper methods. Data from these algorithms were ranked using the geometric mean of ranks of each analysis. Ppia, Hprt1 and Ywhaz were the most stable genes across the analysed brain areas and time points. B2m and Actb exhibited the greatest fluctuations, and the results for Gapdh were ambiguous.

Identifiants

pubmed: 35451185
doi: 10.1111/jcmm.17284
pmc: PMC9097850
doi:

Substances chimiques

Actins 0
Glyceraldehyde-3-Phosphate Dehydrogenases EC 1.2.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3060-3067

Subventions

Organisme : National Science Center in Poland
ID : 2016/21/B/NZ4/03294
Organisme : National Science Center in Poland
ID : 2016/21/D/NZ4/03302
Organisme : European Commission
ID : POWR.03.02.00-00-I013/16

Informations de copyright

© 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Références

Neurochem Res. 2017 Aug;42(8):2354-2362
pubmed: 28424948
J Cell Mol Med. 2022 May;26(10):3060-3067
pubmed: 35451185
Neurol Res. 2006 Dec;28(8):831-6
pubmed: 17288740
PLoS One. 2017 Oct 18;12(10):e0186243
pubmed: 29045497
Biotechnol Lett. 2004 Mar;26(6):509-15
pubmed: 15127793
Brain Res Mol Brain Res. 2000 Jan 10;75(1):143-9
pubmed: 10648898
BMC Mol Biol. 2009 Jun 16;10:57
pubmed: 19531214
J Neurosci Res. 2004 May 15;76(4):512-8
pubmed: 15114623
Neuropharmacology. 2020 Jul;171:108088
pubmed: 32277944
Neuron. 2012 Mar 22;73(6):1100-7
pubmed: 22445338
Cancer Res. 2004 Aug 1;64(15):5245-50
pubmed: 15289330
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Acta Anaesthesiol Scand. 2007 Feb;51(2):158-64
pubmed: 17073862
Sci Rep. 2019 May 3;9(1):6883
pubmed: 31053801
J Neurosci Methods. 2006 Sep 30;156(1-2):101-10
pubmed: 16554095
BMC Mol Biol. 2008 May 28;9:53
pubmed: 18505597
J Cereb Blood Flow Metab. 2002 Mar;22(3):280-8
pubmed: 11891433
BMC Neurosci. 2018 Feb 1;19(1):3
pubmed: 29390963
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Pharmacol Sci. 2006 May;101(1):52-7
pubmed: 16717400
BMC Mol Biol. 2006 Oct 06;7:33
pubmed: 17026756

Auteurs

Bartosz Pomierny (B)

Department of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.

Weronika Krzyzanowska (W)

Department of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.

Jakub Jurczyk (J)

Department of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.

Beata Strach (B)

Department of Neurology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.

Alicja Skorkowska (A)

Department of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.

Innesa Leonovich (I)

Department of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.

Bogusława Budziszewska (B)

Department of Toxicological Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.

Joanna Pera (J)

Department of Neurology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH